Genetic testing for autism is a set of laboratory tests that look for changes in your child’s DNA that are associated with autism spectrum disorder. These tests can identify a specific genetic cause in roughly 10 to 40 percent of cases, depending on the type of test used and whether the child also has intellectual disability. No single “autism gene” exists. Instead, hundreds of genes have been linked to autism risk, and genetic testing searches for missing, extra, or misspelled segments across many of them.
A genetic cause won’t be found for every child on the spectrum, and a positive finding doesn’t predict how severe symptoms will be. Still, testing can provide concrete answers for families, guide medical monitoring, shape therapy choices, and inform future family planning.
What Genetic Testing Actually Looks For
Your DNA is packaged into 23 pairs of chromosomes, and the genes on those chromosomes are essentially instruction manuals for building proteins. Genetic testing for autism searches for two broad categories of problems: large chunks of genetic material that are missing or duplicated, and tiny “spelling mistakes” within individual genes that cause them to malfunction.
A helpful analogy from David Miller, a geneticist at Boston Children’s Hospital, frames it this way: imagine your genes are books in a library. One type of test walks into the library and checks whether entire sections of books are missing from the shelves. Another type opens thousands of those books and reads them letter by letter, looking for typos. Both approaches catch different kinds of problems, which is why more than one test is often needed.
Researchers maintain a continuously updated database of autism-associated genes, scored by the strength of the evidence linking each one to the condition. New genetic links to autism are discovered regularly, which means a test that comes back negative today could potentially yield results if reanalyzed with newer data in the future.
Types of Tests Used
Chromosomal Microarray (CMA)
Chromosomal microarray uses molecular probes to scan all 23 pairs of chromosomes for extra or missing copies of genes. It’s been a standard first-line test for children with developmental differences since around 2010, and most insurance providers cover it. In studies involving thousands of patients with developmental delays, autism, or congenital differences, CMA identifies a clinically significant genetic finding in about 5 to 18 percent of cases, with an overall average near 12 percent.
Whole Exome Sequencing (WES)
Where microarray looks at the big picture, exome sequencing zooms in. It reads the roughly one percent of your DNA that codes for proteins, hunting for single-letter errors that microarray would miss. A large review found that exome sequencing had a diagnostic yield of about 36 percent for neurodevelopmental disorders, roughly double that of microarray. For children with autism alone (without intellectual disability), the yield is lower, closer to 2 to 3 percent. When autism occurs alongside intellectual disability or significant developmental delay, the yield rises to 13 to 23 percent.
Based on these numbers, an expert panel has recommended that exome sequencing be adopted as the first test for unexplained neurodevelopmental disorders, rather than starting with microarray. In practice, the order of testing may vary depending on your medical center and insurance requirements.
Fragile X Testing
Fragile X syndrome is one of the most common inherited causes of intellectual disability, and it frequently overlaps with autism. The CDC recommends that any child with unexplained developmental delay, intellectual disability, or autism receive genetic testing for Fragile X specifically. One reason this matters: there doesn’t have to be a family history of Fragile X for a child to have it. The mutation responsible can expand as it passes from one generation to the next, so a parent who carries a smaller, silent version of the change can have a child with the full condition.
How the Process Works
The testing itself is straightforward. A sample of DNA is collected, typically through a simple blood draw or a buccal swab (a soft brush rubbed along the inside of the cheek). Swab collection is available at many labs specifically because drawing blood from young children can be stressful. The sample is sent to a laboratory for analysis, and results generally take several weeks, though the exact turnaround depends on the type of test ordered.
Sometimes testing a parent’s DNA is also necessary. If a variant is found in the child, labs often check whether it was inherited from a parent or arose spontaneously. This “segregation testing” can push the diagnostic yield higher. In one study, it increased the overall rate of confirmed diagnoses from 12.5 percent to 17.1 percent. It also helps clarify whether the variant is likely to recur in future pregnancies.
What a Genetic Counselor Does
Most families going through this process will work with a genetic counselor before and after testing. Before the test, the counselor collects a detailed family history, explains what the test can and cannot reveal, and walks through “what if” scenarios so the family feels prepared for different outcomes. After results come back, the counselor translates the findings into plain language, often presenting information in multiple formats (visual diagrams, written summaries, analogies) to make sure everything is understood. They also provide follow-up calls, connect families with support resources, and create space to process the emotional weight of a genetic diagnosis.
What Results Can and Cannot Tell You
A positive result, meaning a known autism-related genetic variant is found, can be genuinely useful. It provides a concrete explanation for a child’s developmental differences, which many families describe as a relief after months or years of uncertainty. It can also point toward specific medical concerns to monitor (some genetic syndromes carry risks for heart, kidney, or seizure issues), connect the family to condition-specific support groups, and inform decisions about having more children.
What genetic testing cannot do is predict the future. A genetic variant linked to autism does not tell you how a child will behave, how well they will communicate, or how independent they will become. The same variant can look very different from one person to the next. Environmental factors also play a role in how autism develops, and no genetic test can account for those. In some cases, a variant of “uncertain significance” is found, meaning the lab detected a change in DNA but there isn’t enough scientific evidence yet to say whether it’s causing problems. These ambiguous results can be frustrating, though they may be reclassified as knowledge advances.
It’s also worth knowing that a negative result doesn’t rule out a genetic contribution to autism. Current tests only detect known types of genetic changes in well-studied regions of DNA. Many genetic factors involved in autism simply haven’t been identified yet.
Cost and Insurance Coverage
Genetic testing costs range from under $100 to more than $2,000, depending on the complexity of the test. A targeted test for a single condition like Fragile X sits at the lower end. Whole exome sequencing, which reads thousands of genes, falls at the higher end. Costs increase further if multiple family members need testing to interpret the child’s results.
Chromosomal microarray is covered by most insurance providers as a standard diagnostic tool. Coverage for exome sequencing varies more widely and may require prior authorization or documentation that simpler tests didn’t provide an answer. If cost is a concern, your ordering provider or genetic counselor can often help navigate coverage requirements or identify financial assistance programs offered by testing laboratories.